Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000427096 | SCV000526700 | likely benign | not specified | 2018-01-25 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000711319 | SCV000700475 | uncertain significance | not provided | 2017-01-16 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000711319 | SCV000841660 | likely benign | not provided | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001089331 | SCV001019990 | likely benign | Carnitine palmitoyltransferase II deficiency | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001089331 | SCV001454130 | likely benign | Carnitine palmitoyltransferase II deficiency | 2020-04-30 | no assertion criteria provided | clinical testing |